Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexaria Bioscience (LEXX) Accumulated Depreciation & Amortization (2018 - 2025)

Lexaria Bioscience's Accumulated Depreciation & Amortization history spans 4 years, with the latest figure at $12009.0 for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $12009.0; the TTM value through Nov 2025 reached $12009.0, changed N/A, while the annual FY2024 figure was $42448.0, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $12009.0 at Lexaria Bioscience, down from $39215.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $42448.0 in Q3 2024 and bottomed at $12009.0 in Q4 2025.